2024-12-11

Artivila Biopharma Announces Clearances of IND Applications for ARD-885 by Chine

ShenZhen, Guangdong, China. December 11, 2024- Artivila Biopharma today announced that the Chinese NMPA and the United States FDA have approved its IND applications for its small molecule new drug ARD-885 for the treatment of rheumatoid arthritis.